1. Home
  2. BHVN vs LGND Comparison

BHVN vs LGND Comparison

Compare BHVN & LGND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Biohaven Ltd.

BHVN

Biohaven Ltd.

HOLD

Current Price

$11.54

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Logo Ligand Pharmaceuticals Incorporated

LGND

Ligand Pharmaceuticals Incorporated

HOLD

Current Price

$189.25

Market Cap

3.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BHVN
LGND
Founded
2013
1987
Country
United States
United States
Employees
N/A
68
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
3.9B
IPO Year
2017
1992

Fundamental Metrics

Financial Performance
Metric
BHVN
LGND
Price
$11.54
$189.25
Analyst Decision
Buy
Strong Buy
Analyst Count
16
8
Target Price
$29.79
$144.71
AVG Volume (30 Days)
3.5M
139.7K
Earning Date
11-10-2025
08-05-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$181,488,000.00
Revenue This Year
N/A
$18.41
Revenue Next Year
$2,219.74
$18.87
P/E Ratio
N/A
N/A
Revenue Growth
N/A
53.40
52 Week Low
$7.48
$81.74
52 Week High
$44.28
$129.90

Technical Indicators

Market Signals
Indicator
BHVN
LGND
Relative Strength Index (RSI) 57.02 45.58
Support Level $8.29 $179.65
Resistance Level $11.71 $192.44
Average True Range (ATR) 0.72 6.57
MACD 0.47 -2.06
Stochastic Oscillator 95.32 31.70

Price Performance

Historical Comparison
BHVN
LGND

About BHVN Biohaven Ltd.

Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.

About LGND Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.

Share on Social Networks: